Between 2012 and 2022, venture capital investment in gastroenterology surged to $33.34 billion across 3,419 deals, growing at a compound annual rate of 15.7%. The majority of funding went to biotechnology and pharmaceuticals (65%), followed by medical devices and supplies. Notably, there was a 141% spike in investment from 2019 to 2020, highlighting growing confidence in GI innovation.
Keep Reading
Add A Comment